Yu-Hsin Lin sold $19.1M of Belite Bio (BLTE)

Executed Sep 4, disclosed Sep 9, 5 days later.

Value, as filed

$19.1M

100,435 sh across 19 lots

Executed

Sep 4

the trade date, as filed

Disclosed

Sep 9

5 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

YL Yu-Hsin Lin Chief Executive Officer profile →

Yu-Hsin Lin (Chief Executive Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Belite Bio, Inc (BLTE). The largest single filing was $19.1M of BLTE (100,435 sh across 19 lots, as filed), executed Sep 4.

The name

BLTE Belite Bio, Inc BLTE · Healthcare · 7 filings in 24 months ticker →

Healthcare · Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Yu-Hsin Lin in BLTE

BLTESALE Belite Bio, Inc $1.6M
9,000 sh across 3 lots
Exec Apr 9
Filed Apr 13 · 5:30 PM ET